Drug Information
Drug (ID: DG01675) and It's Reported Resistant Information
| Name |
AMGMDS3
|
||||
|---|---|---|---|---|---|
| Synonyms |
AMGMDS3; Q59770979
Click to Show/Hide
|
||||
| Structure |
|
||||
| Drug Resistance Disease(s) |
Disease(s) with Resistance Information Discovered by Cell Line Test for This Drug
(1 diseases)
[1]
|
||||
| Click to Show/Hide the Molecular Information and External Link(s) of This Drug | |||||
| Formula |
9
|
||||
| IsoSMILES |
CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl
|
||||
| InChI |
InChI=1S/C26H29Cl2NO5/c1-4-20(25(33)34-5-2)29-21(30)14-26(3,15-22(31)32)23(16-8-6-10-18(27)12-16)24(29)17-9-7-11-19(28)13-17/h6-13,20,23-24H,4-5,14-15H2,1-3H3,(H,31,32)/t20-,23+,24+,26-/m0/s1
|
||||
| InChIKey |
SZACTBIUKXKQGM-YLJDOISLSA-N
|
||||
| PubChem CID | |||||
Type(s) of Resistant Mechanism of This Drug
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | |||||||||||||
|
|
|||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.R273H (c.818G>A) |
|||||||||||
| Wild Type Structure | Method: X-ray diffraction | Resolution: 2.05 Å | |||||||||||
| Mutant Type Structure | Method: X-ray diffraction | Resolution: 1.98 Å | |||||||||||
| Download The Information of Sequence | Download The Structure File | ||||||||||||
-
S
S
S
S
S
S
V
V
P
P
S
S
100
|
Q
Q
K
K
T
T
Y
Y
Q
Q
G
G
S
S
Y
Y
G
G
F
F
110
|
R
R
L
L
G
G
F
F
L
L
H
H
S
S
G
G
T
T
A
A
120
|
K
K
S
S
V
V
T
T
C
C
T
T
Y
Y
S
S
P
P
A
A
130
|
L
L
N
N
K
K
M
L
F
F
C
C
Q
Q
L
L
A
A
K
K
140
|
T
T
C
C
P
P
V
V
Q
Q
L
L
W
W
V
V
D
D
S
S
150
|
T
T
P
P
P
P
P
P
G
G
T
T
R
R
V
V
R
R
A
A
160
|
M
M
A
A
I
I
Y
Y
K
K
Q
Q
S
S
Q
Q
H
H
M
M
170
|
T
T
E
E
V
V
V
V
R
R
R
R
C
C
P
P
H
H
H
H
180
|
E
E
R
R
C
C
S
S
D
D
S
S
D
D
G
G
L
L
A
A
190
|
P
P
P
P
Q
Q
H
H
L
L
I
I
R
R
V
V
E
E
G
G
200
|
N
N
L
L
R
R
V
A
E
E
Y
Y
L
L
D
D
D
D
R
R
210
|
N
N
T
T
F
F
R
R
H
H
S
S
V
V
V
V
V
V
P
P
220
|
Y
Y
E
E
P
P
P
P
E
E
V
V
G
G
S
S
D
D
C
C
230
|
T
T
T
T
I
I
H
H
Y
Y
N
N
Y
Y
M
M
C
C
N
Y
240
|
S
S
S
S
C
C
M
M
G
G
G
G
M
M
N
N
R
R
R
R
250
|
P
P
I
I
L
L
T
T
I
I
I
I
T
T
L
L
E
E
D
D
260
|
S
S
S
S
G
G
N
N
L
L
L
L
G
G
R
R
N
D
S
S
270
|
F
F
E
E
V
V
R
H
V
V
C
C
A
A
C
C
P
P
G
G
280
|
R
R
D
D
R
R
R
R
T
T
E
E
E
E
E
E
N
N
L
L
290
|
R
R
K
K
K
K
G
G
E
E
P
P
H
H
H
H
E
E
L
L
300
|
P
P
P
P
G
G
S
S
T
T
K
K
R
R
A
A
L
L
P
P
310
|
N
N
N
N
T
T
|
|||||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.R273H (c.818G>A) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.V157F (c.469G>T) |
|||||||||||
| Wild Type Structure | Method: X-ray diffraction | Resolution: 2.05 Å | |||||||||||
| Mutant Type Structure | Method: X-ray diffraction | Resolution: 1.50 Å | |||||||||||
| Download The Information of Sequence | Download The Structure File | ||||||||||||
-
-
A
S
S
S
S
S
S
V
V
P
P
S
S
100
|
Q
Q
K
K
T
T
Y
Y
Q
Q
G
G
S
S
Y
Y
G
G
F
F
110
|
R
R
L
L
G
G
F
F
L
L
H
H
S
S
G
G
T
T
A
A
120
|
K
K
S
S
V
V
T
T
C
C
T
T
Y
Y
S
S
P
P
A
A
130
|
L
L
N
N
K
K
M
M
F
F
C
C
Q
Q
L
L
A
A
K
K
140
|
T
T
C
C
P
P
V
V
Q
Q
L
L
W
W
V
V
D
D
S
S
150
|
T
T
P
P
P
P
P
P
G
G
T
T
R
R
V
F
R
R
A
A
160
|
M
M
A
A
I
I
Y
Y
K
K
Q
Q
S
S
Q
Q
H
H
M
M
170
|
T
T
E
E
V
V
V
V
R
R
R
R
C
C
P
P
H
H
H
H
180
|
E
E
R
R
C
C
S
S
D
D
S
S
D
D
G
G
L
L
A
A
190
|
P
P
P
P
Q
Q
H
H
L
L
I
I
R
R
V
V
E
E
G
G
200
|
N
N
L
L
R
R
V
V
E
E
Y
Y
L
L
D
D
D
D
R
R
210
|
N
N
T
T
F
F
R
R
H
H
S
S
V
V
V
V
V
V
P
P
220
|
Y
Y
E
E
P
P
P
P
E
E
V
V
G
G
S
S
D
D
C
C
230
|
T
T
T
T
I
I
H
H
Y
Y
N
N
Y
Y
M
M
C
C
N
N
240
|
S
S
S
S
C
C
M
M
G
G
G
G
M
M
N
N
R
R
R
R
250
|
P
P
I
I
L
L
T
T
I
I
I
I
T
T
L
L
E
E
D
D
260
|
S
S
S
S
G
G
N
N
L
L
L
L
G
G
R
R
N
N
S
S
270
|
F
F
E
E
V
V
R
R
V
V
C
C
A
A
C
C
P
P
G
G
280
|
R
R
D
D
R
R
R
R
T
T
E
E
E
E
E
E
N
N
L
L
290
|
R
R
K
K
K
K
G
G
E
E
P
P
H
H
H
H
E
E
L
L
300
|
P
P
P
P
G
G
S
S
T
T
K
K
R
R
A
A
L
L
P
P
310
|
N
N
N
N
T
T
|
|||||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.V157F (c.469G>T) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.Y220C (c.659A>G) |
|||||||||||
| Wild Type Structure | Method: X-ray diffraction | Resolution: 2.05 Å | |||||||||||
| Mutant Type Structure | Method: X-ray diffraction | Resolution: 1.24 Å | |||||||||||
| Download The Information of Sequence | Download The Structure File | ||||||||||||
-
S
S
S
S
S
S
V
V
P
P
S
S
100
|
Q
Q
K
K
T
T
Y
Y
Q
Q
G
G
S
S
Y
Y
G
G
F
F
110
|
R
R
L
L
G
G
F
F
L
L
H
H
S
S
G
G
T
T
A
A
120
|
K
K
S
S
V
V
T
T
C
C
T
T
Y
Y
S
S
P
P
A
A
130
|
L
L
N
N
K
K
M
L
F
F
C
C
Q
Q
L
L
A
A
K
K
140
|
T
T
C
C
P
P
V
V
Q
Q
L
L
W
W
V
V
D
D
S
S
150
|
T
T
P
P
P
P
P
P
G
G
T
T
R
R
V
V
R
R
A
A
160
|
M
M
A
A
I
I
Y
Y
K
K
Q
Q
S
S
Q
Q
H
H
M
M
170
|
T
T
E
E
V
V
V
V
R
R
R
R
C
C
P
P
H
H
H
H
180
|
E
E
R
R
C
C
S
S
D
D
S
S
D
D
G
G
L
L
A
A
190
|
P
P
P
P
Q
Q
H
H
L
L
I
I
R
R
V
V
E
E
G
G
200
|
N
N
L
L
R
R
V
A
E
E
Y
Y
L
L
D
D
D
D
R
R
210
|
N
N
T
T
F
F
R
R
H
H
S
S
V
V
V
V
V
V
P
P
220
|
Y
C
E
E
P
P
P
P
E
E
V
V
G
G
S
S
D
D
C
C
230
|
T
T
T
T
I
I
H
H
Y
Y
N
N
Y
Y
M
M
C
C
N
Y
240
|
S
S
S
S
C
C
M
M
G
G
G
G
M
M
N
N
R
R
R
R
250
|
P
P
I
I
L
L
T
T
I
I
I
I
T
T
L
L
E
E
D
D
260
|
S
S
S
S
G
G
N
N
L
L
L
L
G
G
R
R
N
D
S
S
270
|
F
F
E
E
V
V
R
R
V
V
C
C
A
A
C
C
P
P
G
G
280
|
R
R
D
D
R
R
R
R
T
T
E
E
E
E
E
E
N
N
L
L
290
|
R
R
K
K
K
K
G
G
E
E
P
P
H
H
H
H
E
E
L
L
300
|
P
P
P
P
G
G
S
S
T
T
K
K
R
R
A
A
L
L
P
P
310
|
N
N
N
N
T
T
|
|||||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.Y220C (c.659A>G) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.R249S (c.747G>C) |
|||||||||||
| Wild Type Structure | Method: X-ray diffraction | Resolution: 1.92 Å | |||||||||||
| Mutant Type Structure | Method: X-ray diffraction | Resolution: 1.90 Å | |||||||||||
| Download The Information of Sequence | Download The Structure File | ||||||||||||
-
P
-
L
-
S
S
S
S
S
S
V
V
P
P
S
S
100
|
Q
Q
K
K
T
T
Y
Y
Q
Q
G
G
S
S
Y
Y
G
G
F
F
110
|
R
R
L
L
G
G
F
F
L
L
H
H
S
S
G
G
T
T
A
A
120
|
K
K
S
S
V
V
T
T
C
C
T
T
Y
Y
S
S
P
P
A
A
130
|
L
L
N
N
K
K
M
L
F
F
C
C
Q
Q
L
L
A
A
K
K
140
|
T
T
C
C
P
P
V
V
Q
Q
L
L
W
W
V
V
D
D
S
S
150
|
T
T
P
P
P
P
P
P
G
G
T
T
R
R
V
V
R
R
A
A
160
|
M
M
A
A
I
I
Y
Y
K
K
Q
Q
S
S
Q
Q
H
H
M
M
170
|
T
T
E
E
V
V
V
V
R
R
R
R
C
C
P
P
H
H
H
H
180
|
E
E
R
R
C
C
S
S
D
D
S
S
D
D
G
G
L
L
A
A
190
|
P
P
P
P
Q
Q
H
H
L
L
I
I
R
R
V
V
E
E
G
G
200
|
N
N
L
L
R
R
V
A
E
E
Y
Y
L
L
D
D
D
D
R
R
210
|
N
N
T
T
F
F
R
R
H
H
S
S
V
V
V
V
V
V
P
P
220
|
Y
Y
E
E
P
P
P
P
E
E
V
V
G
G
S
S
D
D
C
C
230
|
T
T
T
T
I
I
H
H
Y
Y
N
N
Y
Y
M
M
C
C
N
Y
240
|
S
S
S
S
C
C
M
M
G
G
G
G
M
M
N
N
R
R
R
S
250
|
P
P
I
I
L
L
T
T
I
I
I
I
T
T
L
L
E
E
D
D
260
|
S
S
S
S
G
G
N
N
L
L
L
L
G
G
R
R
N
D
S
S
270
|
F
F
E
E
V
V
R
R
V
V
C
C
A
A
C
C
P
P
G
G
280
|
R
R
D
D
R
R
R
R
T
T
E
E
E
E
E
E
N
N
L
L
290
|
R
R
K
K
K
K
G
G
E
E
P
P
H
H
H
H
E
E
L
L
300
|
P
P
P
P
G
G
S
S
T
T
K
K
R
R
A
A
L
L
P
P
310
|
N
N
N
N
T
T
H
-
H
-
H
-
H
-
H
-
H
-
|
|||||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.R249S (c.747G>C) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.R273C (c.817C>T) |
|||||||||||
| Wild Type Structure | Method: X-ray diffraction | Resolution: 2.05 Å | |||||||||||
| Mutant Type Structure | Method: X-ray diffraction | Resolution: 1.80 Å | |||||||||||
| Download The Information of Sequence | Download The Structure File | ||||||||||||
-
S
S
S
S
S
S
V
V
P
P
S
S
100
|
Q
Q
K
K
T
T
Y
Y
Q
Q
G
G
S
S
Y
Y
G
G
F
F
110
|
R
R
L
L
G
G
F
F
L
L
H
H
S
S
G
G
T
T
A
A
120
|
K
K
S
S
V
V
T
T
C
C
T
T
Y
Y
S
S
P
P
A
A
130
|
L
L
N
N
K
K
M
L
F
F
C
C
Q
Q
L
L
A
A
K
K
140
|
T
T
C
C
P
P
V
V
Q
Q
L
L
W
W
V
V
D
D
S
S
150
|
T
T
P
P
P
P
P
P
G
G
T
T
R
R
V
V
R
R
A
A
160
|
M
M
A
A
I
I
Y
Y
K
K
Q
Q
S
S
Q
Q
H
H
M
M
170
|
T
T
E
E
V
V
V
V
R
R
R
R
C
C
P
P
H
H
H
H
180
|
E
E
R
R
C
C
S
S
D
D
S
S
D
D
G
G
L
L
A
A
190
|
P
P
P
P
Q
Q
H
H
L
L
I
I
R
R
V
V
E
E
G
G
200
|
N
N
L
L
R
R
V
A
E
E
Y
Y
L
L
D
D
D
D
R
R
210
|
N
N
T
T
F
F
R
R
H
H
S
S
V
V
V
V
V
V
P
P
220
|
Y
Y
E
E
P
P
P
P
E
E
V
V
G
G
S
S
D
D
C
C
230
|
T
T
T
T
I
I
H
H
Y
Y
N
N
Y
Y
M
M
C
C
N
Y
240
|
S
S
S
S
C
C
M
M
G
G
G
G
M
M
N
N
R
R
R
R
250
|
P
P
I
I
L
L
T
T
I
I
I
I
T
T
L
L
E
E
D
D
260
|
S
S
S
S
G
G
N
N
L
L
L
L
G
G
R
R
N
D
S
S
270
|
F
F
E
E
V
V
R
C
V
V
C
C
A
A
C
C
P
P
G
G
280
|
R
R
D
D
R
R
R
R
T
T
E
E
E
E
E
E
N
N
L
L
290
|
R
R
K
K
K
K
G
G
E
E
P
P
H
H
H
H
E
E
L
L
300
|
P
P
P
P
G
G
S
S
T
T
K
K
R
R
A
A
L
L
P
P
310
|
N
N
N
N
T
T
|
|||||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.R273C (c.817C>T) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.R175H (c.524G>A) |
|||||||||||
| Wild Type Structure | Method: X-ray diffraction | Resolution: 2.37 Å | |||||||||||
| Mutant Type Structure | Method: X-ray diffraction | Resolution: 2.38 Å | |||||||||||
| Download The Information of Sequence | Download The Structure File | ||||||||||||
-
H
H
M
M
170
|
T
T
E
E
V
V
V
V
R
R
R
H
C
C
|
|||||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.R175H (c.524G>A) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.R280K (c.839G>A) |
|||||||||||
| Wild Type Structure | Method: X-ray diffraction | Resolution: 2.05 Å | |||||||||||
| Mutant Type Structure | Method: X-ray diffraction | Resolution: 2.00 Å | |||||||||||
| Download The Information of Sequence | Download The Structure File | ||||||||||||
-
S
-
S
-
S
-
V
V
P
P
S
S
100
|
Q
Q
K
K
T
T
Y
Y
Q
Q
G
G
S
S
Y
Y
G
G
F
F
110
|
R
R
L
L
G
G
F
F
L
L
H
H
S
S
G
G
T
T
A
A
120
|
K
K
S
S
V
V
T
T
C
C
T
T
Y
Y
S
S
P
P
A
A
130
|
L
L
N
N
K
K
M
M
F
F
C
C
Q
Q
L
L
A
A
K
K
140
|
T
T
C
C
P
P
V
V
Q
Q
L
L
W
W
V
V
D
D
S
S
150
|
T
T
P
P
P
P
P
P
G
G
T
T
R
R
V
V
R
R
A
A
160
|
M
M
A
A
I
I
Y
Y
K
K
Q
Q
S
S
Q
Q
H
H
M
M
170
|
T
T
E
E
V
V
V
V
R
R
R
R
C
C
P
P
H
H
H
H
180
|
E
E
R
R
C
C
S
S
D
D
S
S
D
D
G
G
L
L
A
A
190
|
P
P
P
P
Q
Q
H
H
L
L
I
I
R
R
V
V
E
E
G
G
200
|
N
N
L
L
R
R
V
V
E
E
Y
Y
L
L
D
D
D
D
R
R
210
|
N
N
T
T
F
F
R
R
H
H
S
S
V
V
V
V
V
V
P
P
220
|
Y
Y
E
E
P
P
P
P
E
E
V
V
G
G
S
S
D
D
C
C
230
|
T
T
T
T
I
I
H
H
Y
Y
N
N
Y
Y
M
M
C
C
N
N
240
|
S
S
S
S
C
C
M
M
G
G
G
G
M
M
N
N
R
R
R
R
250
|
P
P
I
I
L
L
T
T
I
I
I
I
T
T
L
L
E
E
D
D
260
|
S
S
S
S
G
G
N
N
L
L
L
L
G
G
R
R
N
N
S
S
270
|
F
F
E
E
V
V
R
R
V
V
C
C
A
A
C
C
P
P
G
G
280
|
R
K
D
D
R
R
R
R
T
T
E
E
E
E
E
E
N
N
L
L
290
|
R
-
K
-
K
-
G
-
E
-
P
-
H
-
H
-
E
-
L
-
300
|
P
-
P
-
G
-
S
-
T
-
K
-
R
-
A
-
L
-
P
-
310
|
N
-
N
-
T
-
|
|||||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.R280K (c.839G>A) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.G245S (c.733G>A) |
|||||||||||
| Wild Type Structure | Method: X-ray diffraction | Resolution: 2.05 Å | |||||||||||
| Mutant Type Structure | Method: X-ray diffraction | Resolution: 2.15 Å | |||||||||||
| Download The Information of Sequence | Download The Structure File | ||||||||||||
-
S
S
S
S
S
S
V
V
P
P
S
S
100
|
Q
Q
K
K
T
T
Y
Y
Q
Q
G
G
S
S
Y
Y
G
G
F
F
110
|
R
R
L
L
G
G
F
F
L
L
H
H
S
S
G
G
T
T
A
A
120
|
K
K
S
S
V
V
T
T
C
C
T
T
Y
Y
S
S
P
P
A
A
130
|
L
L
N
N
K
K
M
M
F
F
C
C
Q
Q
L
L
A
A
K
K
140
|
T
T
C
C
P
P
V
V
Q
Q
L
L
W
W
V
V
D
D
S
S
150
|
T
T
P
P
P
P
P
P
G
G
T
T
R
R
V
V
R
R
A
A
160
|
M
M
A
A
I
I
Y
Y
K
K
Q
Q
S
S
Q
Q
H
H
M
M
170
|
T
T
E
E
V
V
V
V
R
R
R
R
C
C
P
P
H
H
H
H
180
|
E
E
R
R
C
C
S
S
D
D
S
S
D
D
G
G
L
L
A
A
190
|
P
P
P
P
Q
Q
H
H
L
L
I
I
R
R
V
V
E
E
G
G
200
|
N
N
L
L
R
R
V
V
E
E
Y
Y
L
L
D
D
D
D
R
R
210
|
N
N
T
T
F
F
R
R
H
H
S
S
V
V
V
V
V
V
P
P
220
|
Y
Y
E
E
P
P
P
P
E
E
V
V
G
G
S
S
D
D
C
C
230
|
T
T
T
T
I
I
H
H
Y
Y
N
N
Y
Y
M
M
C
C
N
N
240
|
S
S
S
S
C
C
M
M
G
G
G
S
M
M
N
N
R
R
R
R
250
|
P
P
I
I
L
L
T
T
I
I
I
I
T
T
L
L
E
E
D
D
260
|
S
S
S
S
G
G
N
N
L
L
L
L
G
G
R
R
N
N
S
S
270
|
F
F
E
E
V
V
R
R
V
V
C
C
A
A
C
C
P
P
G
G
280
|
R
R
D
D
R
R
R
R
T
T
E
E
E
E
E
E
N
N
L
L
290
|
R
R
K
K
K
K
G
G
E
-
P
-
H
-
H
-
E
-
L
-
300
|
P
-
P
-
G
-
S
-
T
-
K
-
R
-
A
-
L
-
P
-
310
|
N
-
N
-
T
-
|
|||||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.G245S (c.733G>A) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.R158H (c.473G>A) |
|||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.R158H (c.473G>A) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.R158L (c.473G>T) |
|||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.R158L (c.473G>T) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.R248W (c.742C>T) |
|||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.R248W (c.742C>T) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.R248Q (c.743G>A) |
|||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.R248Q (c.743G>A) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
| Key Molecule: Cellular tumor antigen p53 (TP53) | [1] | ||||||||||||
| Resistant Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||||||||||
| Molecule Alteration | Missense mutation | p.R280T (c.839G>C) |
|||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |||||||||
| Capan-2 cells | Pancreas | Homo sapiens (Human) | CVCL_0026 | ||||||||||
| MDA-MB-453 cells | Breast | Homo sapiens (Human) | CVCL_0418 | ||||||||||
| MG-63 cells | Bone | Homo sapiens (Human) | CVCL_0426 | ||||||||||
| NCI-H82 cells | Pleural effusion | Homo sapiens (Human) | CVCL_1591 | ||||||||||
| Experiment for Molecule Alteration |
Immunoblotting analysis | ||||||||||||
| Experiment for Drug Resistance |
Fluorescence microscopy assay | ||||||||||||
| Mechanism Description | The missense mutation p.R280T (c.839G>C) in gene TP53 cause the resistance of AMGMDS3 by unusual activation of pro-survival pathway | ||||||||||||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
